Faculty Presentations
Claus F. Vogelmeier, MD |
Fig. 01 -
Title Slide
Fig. 02 -
Disclosures
Fig. 03 -
Diagnosis
Fig. 04 -
The Past
Fig. 05 -
The Presence
Fig. 06 -
Consequences
Fig. 07 -
Prevalence vs Definition
Fig. 08 -
Approach to Diseases
Fig. 09 -
Perform Spirometry
Fig. 10 -
Asthma, COPD & ACOS
Fig. 11 -
Variable: Post PD
Fig. 12 -
Bronchodilator Responsiveness
Fig. 13 -
BTS
Fig. 14 -
Specialized Investigations
Fig. 15 -
FENO
Fig. 16 -
ATS Guideline
Fig. 17 -
Pilot Study
Fig. 18 -
Pilot Study - Results
Fig. 19 -
Benefit - Risk Ratio
Fig. 20 -
Initial Treatment
Fig. 21 -
Initial Therapy
Fig. 22 -
Specialised Investigations
Fig. 23 -
ACOS
TODO, let Pete know of any updates to this content
Six (6) provocative statements concerning clinical treatment of IBD. Each statement is presented as 5 steps:Step 1: the statement & introduction, + 5 possible opinions of that statement -- please choose one
Step 2: a graph of an international survey’s opinions of that statement
Step 3: a literature review for that statement
Step 4: a graph comparing the faculty's vs an international survey’s opinions, + faculty discussion
Step 5: a brief faculty summary, plus the list of references.
Please click on any Statement or any Step tab to read this publication in the order you prefer.